News
EASD: Studies slam cardiovascular safety of sulfonylureas
- Author:
- Sara Freeman
Publish date: October 13, 2015
News

ESC: Strong coffee raises hypertension and prediabetes risk
- Author:
- Sara Freeman
Publish date: October 13, 2015
News
EASD: Once-weekly omarigliptin as effective as daily sitagliptin
- Author:
- Sara Freeman
Publish date: October 2, 2015
News
EASD: Once-weekly omarigliptin as effective as daily sitagliptin
- Author:
- Sara Freeman
Publish date: October 2, 2015
News
EASD: Monthly incretin-based therapy shows promise in type 2 diabetes
- Author:
- Sara Freeman
Publish date: October 1, 2015
News
Monthly Incretin-based Therapy Shows Promise in Type 2 Diabetes
- Author:
- Sara Freeman
Publish date: October 1, 2015
News

EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetes
- Author:
- Sara Freeman
Publish date: October 1, 2015
News

Lipid-lowering Benefits of Alirocumab Extend to Patients With High-risk Diabetes
- Author:
- Sara Freeman
Publish date: October 1, 2015
News

EASD: Diabetes doubles death risk from many causes
- Author:
- Sara Freeman
Publish date: October 1, 2015
News
EASD: Metformin-induced B12 deficiency linked to diabetic neuropathy
- Author:
- Sara Freeman
Publish date: September 30, 2015
News
Metformin-induced B12 Deficiency Linked to Diabetic Neuropathy
- Author:
- Sara Freeman
Publish date: September 30, 2015
News

EASD: Pre-pregnancy weight, not gestational gain, affects later diabetes risk
- Author:
- Sara Freeman
Publish date: September 26, 2015
News

EASD: SGLT2 inhibitors show potential in 1DM despite DKA concern
- Author:
- Sara Freeman
Publish date: September 25, 2015
News

EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetes
- Author:
- Sara Freeman
Publish date: September 18, 2015
News
EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents
- Author:
- Sara Freeman
Publish date: September 16, 2015
